TACSTD2 and cancer: Of all the cancer types, TACSTD2-high urothelial cancer demonstrated the most significant pattern of lower immune cell infiltration, with a smaller fraction of M1 macrophages, dendritic cells, Tregs, CD8+ T cells, and B cells (P < .05; Figure 4B).